Evaluation for Efficacy and Safety of Azilsartan in Patients with Hypertension

Evaluation for Efficacy and Safety of Azilsartan in Patients with Hypertension - Azilsartan in Hyperetnsives

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008577

Enrollment

Registered

2012-08-01

Start date

2012-09-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

azilsartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: (1) past history of adverse reaction for azilsartan (2) pregnant female or women suspected of being pregnant (3) advanced renal insufficiency

Design outcomes

Primary

Measure	Time frame
blood pressure	—

Secondary

Measure	Time frame
albuminuria, BNP	—

Countries

Japan

Contacts

Public ContactKen-ichi Aihara

The University of Tokushima, Graduate School of Health Biosciences Medicine and Bioregulatory Sciences

aihara@tokuhsima-u.ac.jp088-633-7120

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026